Evidence map›Paper›PMID 42304344›Full record

Observational studyBMC nephrology2026

Association of nutritional indices with hyporesponsiveness to hypoxia-inducible factor-prolyl hydroxylase inhibitors in patients with chronic kidney disease: a single-center retrospective observational study.

Takuya Minamishima, Hiroyuki Mizoguchi, Nobuhiro Nishibori, Hiroaki Ikesue

Abstract readObservational Study
In one paragraph

Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takuya MinamishimaDepartment of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan. minamishima.takuya.r8@f.mail.nagoya-u.ac.jp.
Hiroyuki MizoguchiDepartment of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan.
Nobuhiro NishiboriDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hiroaki IkesueDepartment of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising therapeutic alternatives for renal anemia because their hematopoietic effects are less influenced by inflammation. However, HIF-PHIs did not improve anemia in some cases, even at increasing doses. Since non-hemodialysis patients and various HIF-PHIs have not yet been examined, this study aimed to explore the factors associated with HIF-PHI resistance index (HRI) in all patients with chronic kidney disease (CKD) who received HIF-PHIs.

methodsThis single-center, retrospective observational study included patients with dialysis-dependent or non-dialysis-dependent CKD who received HIF-PHIs. Spearman's rank correlation coefficients were calculated between the HRI and each factor. Factors associated with a high HRI were evaluated using univariate logistic regression analysis, followed by multivariate logistic regression analysis using statistically significant factors as covariates.

resultsThe controlling nutritional status (CONUT) score was strongly correlated with HRI (score ≥ 5 [moderate to severe malnutrition] was associated with a high HRI). Further analysis of daprodustat (n = 38) showed that this association remained significant after adjusting for potential confounders (OR = 2.2; 95% CI, 1.09-4.44; p = 0.028).

conclusionMalnutrition, which is closely associated with anemia, may contribute to the reduced responsiveness to HIF-PHIs. A high HRI may be undesirable for any patient because of safety concerns and economic burden.

Indexed as

AnemiaHypoxia-Inducible Factor-Proline DioxygenasesNutritional StatusProlyl-Hydroxylase InhibitorsRenal Insufficiency, ChronicAgedBarbituratesCyclohexanesFemaleHumansMaleMiddle AgedPyrimidinesRetrospective StudiesBarbituratesCyclohexanesGSK1278863Hypoxia-Inducible Factor-Proline DioxygenasesProlyl-Hydroxylase InhibitorsPyrimidinesChronic kidney diseaseControlling nutritional status scoreHypoxia-inducible factor-prolyl hydroxylase inhibitorNutritional indicesRenal anemia

Identifiers

PMID42304344
PMCPMC13520362

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.